The Role of Stereotactic Radiosurgery in Metastasis to the Spine by Sohn, Seil & Chung, Chun Kee
1
tolerance of the spinal cord, which is highly susceptible to radi-
ation. In recent years, advances in imaging technology and 
computed treatment planning have allowed the safe delivery of 
high-dose radiation to spinal metastases, even when in close 
proximity to the spinal cord. These treatments are administered 
in 1 to 5 fractions of high-dose radiation (to ensure safety), 
which limit the dose delivered to the spinal cord12).
The emerging technique of stereotactic radiosurgery (SRS) 
for spine metastases represents a logical extension of the cur-
rent state-of-the-art of radiation therapy. Stereotactic radiosur-
gery has emerged as a new treatment option for the multidisci-
plinary management of metastases located within or adjacent 
to vertebral bodies and the spinal cord. The goals of stereotactic 
radiosurgery parallel those of brain radiosurgery, that is, to im-
prove local control over conventional fractionated radiation 
therapy and to be effective for the treatment of previously irra-
INTRODUCTION
The world health organization estimated that worldwide, 10 
million people were diagnosed with cancer in 2000, and that 
the cancer incidence rate would increase by 50% to 15 million 
by 2020. Furthermore, as treatment outcomes improve and 
cancer patients have an increased survival21), the incidence and 
prevalence of spinal metastases, which are known to occur in 
30-50% of cancer patients22,27,41), are also set to rise. The majori-
ty of these patients will undergo palliative radiation therapy, 
and the role of radiation therapy for the treatment of metastatic 
tumors of the spine is well established7,23,37).
Conventional radiation therapy (RT) is defined as radiation 
delivered using 1 to 2 beams without high precision or highly 
conformal treatment. Therefore, the effectiveness of conven-
tional radiation therapy has been limited by the poor radiation 
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diated lesions with an acceptable 
safety profile. Herein, we present a 
systematic review regarding the 
value of spinal stereotactic radio-
surgery in the management of spi-
nal metastasis.
MATERIALS AND METHODS
A systematic literature search for 
stereotactic radiosurgery of spine 
metastases was undertaken. Case 
reports or papers describing less 
than 10 spine metastatic patients 
and studies that used intensity 
modulated radiotherapy involving 
more than 5 fractionations were 
excluded.
The search was limited to the 
English literature and was per-
formed using PubMed. References 
and reviews in identified articles 
were also examined for potential 
inclusion. Thirty-one studies met 
all the study inclusion criteria. 
Grades of Recommendation, As-
sessment, Development, and Edu-
cation (GRADE) working group 
criteria as described by Guyatt and 
coworkers35) was used to critically 
evaluate the quality of each dataset 
(Table 1), which was assigned 
high, moderate, low, or very low 
qualities based on the GRADE ap-
proach35). Twenty-three studies 
were classified as ‘low’ and 8 as 
‘very low’. The number of studies 
using Cyberknife (Accuracy Inc., 
Sunny vale, CA, USA) was 21. The 
number of studies using Novalis 
(Brain Lab Inc., Germany) was 7. 
The number of studies using LIN-
AC, Synergy S LINAC (Elekta 
Synergy S 6-MV LINAC) and heli-
cal tomotherapy was 1 each. 
The indication for spinal stereo-
tactic radiosurgery in spine me-
tastasis has evolved over time and 
will continue to evolve as clinical 
experience increases. However, 
surgery is usually reserved for spi-
nal instability and significant neu-
rologic deficits from direct tumor 
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Hospital6,8,9), and Haley et al.18) reported no statistically signifi-
cant difference in pain between SRS and RT groups. 
Local control
Local control rates are reported to be approximately 90%. De-
gen et al.6) demonstrated a 95% local control rate for 58 lesions 
in a mean follow-up of 350 days, and Chang et al.3) reported a 
1-year 84% progression free incidence in 74 lesions. Overall 
long-term radiographic tumor control for progressive spinal 
disease in a series of 500 cases was 88-90% during the median 
21-month follow-up11). Radiographic tumor control rates were 
found to be dependent on primary pathology : breast (100%), 
lung (100%), renal cell (87%), and melanoma (75%)11). 
Recurrent spinal metastasis in previously irradiated 
lesions
Spine SRS is frequently used to treat radiographic tumor pro-
gression after conventional RT or after prior surgery. The ma-
jority of these lesions have undergone irradiation at significant 
spinal cord doses. Thus, further conventional irradiation deliv-
ery could not be indicated for them. However, currently, spine 
stereotactic radiosurgery is often being used as a “salvage” tech-
nique for those cases in which further conventional irradiation 
or open surgery are not appropriate.
Choi et al.4) recently reported 6 and 12 month local control 
rates of 87% and 81%, respectively, in previously irradiated pa-
tients, and Gerszten et al.11) reported an 88% radiographic con-
progression rather than stereotactic radiosurgery. 
The current indications for the use of stereotactic radiosur-
gery as a treatment modality for metastatic spine disease in-
clude pain related to a specific involved vertebral body, radio-
graphic tumor progression as a primary treatment modality for 
progressive neurologic deficits, and adjuvant therapy after open 
surgical intervention. These indications were grouped into four 
general categories, as described by Sahgal et al.34) :
1. Unirradiated patients : spinal metastases in a previously 
unirradiated volume treated by SRS. 
2. Reirradiated patients : spinal metastases in a previously ir-
radiated volume now containing new, recurrent, or progressive 
metastatic disease treated by SRS. 
3. Postoperative patients : spinal metastases treated with SRS 
after open surgical intervention, with or without spinal stabili-
zation. 
4. Mixed patients : mixed populations involving patients in 
the three previous categories. 
RESULTS
Pain and quality of life
Pain is the most frequent indication for the treatment of spi-
nal metastases, and radiation is well known to be effective as a 
treatment for pain associated with spinal malignancies. Fur-
thermore, stereotactic radiosurgery has been reported to be 
highly effective at reducing pain associated with symptomatic 
spinal metastasis5,29), regardless of prior 
treatment by conventional fractionated 
radiotherapy, and to have an overall 
improvement rate of approximately 85-
100%. Pain is reported to decrease usu-
ally within weeks after SRS and occa-
sionally within days5,19,29,33).
Ryu et al.31) reported an overall pain 
control rate of 84% at 1 year after treat-
ment in a series of 49 patients. Gerszten 
et al.11) reported on a mixed population 
that achieved an overall pain improve-
ment rate of 86% (290 of 336 cases) de-
pending on primary histopathology. 
Durable pain improvement was dem-
onstrated in 96% of women with breast 
cancer, in 96% of melanoma cases, in 
94% of cases with renal cell carcinoma, 
and in 93% of lung-cancer cases. Gibbs 
et al.16) reported that 84% of symptom-
atic patients experienced improvement 
or resolution of symptoms after treat-
ment. In addition, excellent pain-con-
trol and quality-of-life results after spi-
nal stereotactic radiosurgery have been 
reported by the Georgetown University 
Fig. 1. A representative case of a 48-year-old female with an isolated painful C3 metastasis. The 
patient experienced pain relief three months after Cyberknife stereotactic radiosurgery. A : 
Preoperative T1 weighted axial MR image with enhancement. B : Axial projection of the isodose line 
of the treatment plan. The 77% isodose line represents the prescribed dose of 31.7 Gy (5 fractions), 
the tumor volume is 14.5 mL, and the spinal cord received a maximum dose of 25.3 Gy. C : Six-
month postoperative T1 weighted axial MR image with enhancement. D : Two-year postoperative 
T1 weighted axial MR image with enhancement showing good response. MR : magnetic resonance.
C
A
D
B4
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Rock et al.28,31) specifically evaluated the combination of open 
surgery followed by adjuvant SRS in a series of 18 patients and 
achieved a local control rate of 94%, whereas Gerszten et al.10) re-
ported a series of 26 patients treated by SRS after vertebral body 
cement augmentation and achieved a local control rate of 92%. 
Dose recommendation for spine stereotactic 
radiosurgery
The prescribed radiation dose to the tumor is determined 
based on tumor histology, spinal cord, or cauda equina tolerance 
and previous radiation dosage to normal tissue, especially to the 
spinal cord. No large-scale study has yet developed an optimal 
dose for spinal SRS, and no appropriate dose or fractionation 
schedule for metastatic tumors have been firmly established. 
However, spinal SRS has been found to be safe at doses compa-
rable to those used for intracranial radiosurgery without the oc-
currence of radiation-induced neural injury. 
Dose and fractionation schedules are different in each institu-
tion. Single-fraction SRS doses range from 8 to 24 Gy, while hy-
pofractionated regimens consist of 4 Gy×5 fractions, 6 Gy×5 
fractions, 8 Gy×3 fractions, or 9 Gy×3 fractions9). Currently, 
there is no evidence to support one regimen over another34). In 
one recent large series9), 26.4 Gy in 3 fractions was prescribed to 
the 75% isodose surface for radiation naïve lesions. Previously 
irradiated lesions were treated with a mean maximum dose of 
20 Gy (range 12.5-25 Gy)11), a median dose 35 Gy (range 20-
50.4 Gy)3), a median dose of 20 Gy in 5 fractions (range 20-30 
Gy)43), and a median dose 20 Gy (range 10-30 Gy) in 1-5 frac-
tions (median 2). 
Adjacent level failure after stereotactic radiosurgery
One concern that has been raised regarding SRS for spinal 
metastases is whether adjacent levels are included in the radia-
tion field. In the report of University of Pittsburgh Medical Cen-
ter, no cases of tumor progression were encountered at immedi-
ate adjacent levels, thus justifying the treatment of the involved 
spine only11,33). Although they reported failures in 3 out of 49 pa-
tients treated for solitary metastases, no failure was identified in 
adjacent untreated vertebrae33). The implication of these findings 
is that progression in adjacent vertebral bodies is rare, and thus, 
they support SRS treatment of involved spinal levels only3,34). 
Based on these findings, Sahgal concluded that it was possible 
that : 1) failure in the epidural space may have been be due to 
underdosing of the tumor because of strict spinal cord con-
straints, 2) uninvolved adjacent posterior elements should have 
been included in the target volume, and 3) encompassing one 
vertebral body above and below diseased vertebrae was unnec-
essary34).
Safety and complications of stereotactic radiosurgery 
Complications associated with SRS are generally self-limited 
and mild. The minor and limited toxicities reported for spine 
radiosurgery include esophagitis18,19), dysphagia6), diarrhea3,6), 
trol rate in patients, 69% of whom had previously received ra-
diotherapy. Chang et al.3) reported a 1-year actuarial tumor 
progression-free incidence of 84% for fractionated SRS treat-
ment; 56% of their patients received SRS as a retreatment.
Primary treatment modality 
As greater experience is gained, stereotactic radiosurgery 
will probably evolve into an initial upfront treatment for spinal 
metastasis in certain cases, especially for cases of oligometasta-
sis. This is similar to the evolution that occurred over the past 
decade for the treatment of intracranial metastases by radio-
surgery. Additional asymptomatic lesions may be treated by 
SRS to avoid further irradiation to neural elements and further 
bone-marrow suppression and to permit subsequent systemic 
therapy.
Gagnon et al.8) reported a matched-pair analysis in which 18 
patients with breast-cancer spinal metastases treated by SRS 
were compared to 18 matched patients that received conven-
tional external beam radiation therapy (EBRT) upfront. This 
study concluded that salvage SRS is as efficacious as initial frac-
tionated RT without added toxicity. Haley et al.18) recently re-
ported that in terms of pain relief, SRS as a primary treatment 
modality in spinal metastasis was not different from EBRT. 
When used as a primary treatment modality, long term radio-
graphic tumor control was demonstrated in 90% of cases of 
breast, lung, and renal cell carcinoma metastases and in 75% of 
melanoma metastases11). Sheehan et al.36) reported a 100% tu-
mor control rate in lesions that had not previously undergone 
irradiation, and Ryu et al.31) reported the results of a dose-esca-
lation trial in which a series of 49 patients with lesions that had 
not previously undergone fractionated RT demonstrated good 
clinical outcomes. Illustrative case showed an example of good 
response as primary treatment (Fig. 1).
Adjuvant therapy after open surgery
Spinal tumors can be removed from neural structures, allow-
ing immediate decompression. The spine can be instrumented 
if necessary, residual tumor can be safely treated later by SRS, 
and thus, the adjunctive SRS can reduce the chance of repeated 
surgery and possible morbidities from the second surgery. Fur-
thermore, anterior corpectomy with reconstruction procedures 
in certain cases can be avoided successfully by posterior de-
compression and instrumentation alone followed by SRS to the 
remaining anterior lesion. Given the ability to perform spinal 
SRS effectively, the current surgical approach to these lesions 
might be changed. As SRS has the stiff falloff gradient of the 
target dose with negligible skin dose20), such treatments can be 
given soon after surgery instead of after the usual significant 
delay before standard external beam RT is permitted2,25,39). 
Open surgery for spinal metastases will likely evolve in a similar 
manner, whereby intracranial brain tumors are debulked in 
such a way as to avoid neurologic deficits and minimize surgi-
cal morbidity12). 5
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segments of the spinal column, which is known to have a dele-
terious effect on bone marrow reserve in these patients. The 
avoidance of open surgery and the preservation of bone-mar-
row function facilitate continuous chemotherapy in this patient 
population. Furthermore, improved local control, such as that 
demonstrated for intracranial radiosurgery, could translate into 
more effective palliation and potentially longer survival. 
One advantage to patients offered by single-fraction SRS is 
that treatment can be completed in a single day rather than over 
the course of several weeks, which is not inconsequential for 
those with a limited life expectancy. Furthermore, the technique 
may be useful for capitalizing on the possible advantages of ra-
diosensitizers12). In addition, cancer patients may have difficulty 
with access to a radiation-treatment facility for prolonged, daily 
fractionated therapy. Also, for certain tumors such as sarcomas, 
melanomas, and renal cell metastases, a large single fraction of 
irradiation may be radiobiologically advantageous compared to 
prolonged fractionated RT. As opposed to responses to conven-
tional EBRT, responses to high-dose single-fraction radiation or 
SRS have been demonstrated to be histology independent, and 
excellent responses have been observed for radioresistant tu-
mors. Clinical responses such as pain or neurologic deficit im-
provement might also be more rapid after SRS12).
Stereotactic radiosurgery for spinal metastasis has several 
limitations. First, the quality of literature on spinal SRS is poor; 
no randomized controlled study has been conducted. Second, 
SRS is more expensive than conventional RT; according to the 
US Medicare system, the cost of RT is about 80% that of SRS18). 
In the South Korea system, when Cyberknife stereotactic radio-
surgery was done in 3 fractions and RT was done in 10 frac-
tions, stereotactic radiosurgery is two times more expensive 
than 2D RT and similar to 3D RT. Although specific costs are 
likely to differ in other countries, a cost benefit study is required 
before the widespread adoption of SRS. Therefore, we suggest 
that SRS be initially used to treat spinal metastasis and chemo 
resistant tumors. Nonetheless, we believe that the usage of SRS 
will progress in the same manner as brain radiosurgery and 
that eventually it will be routinely used to treat spinal metasta-
sis. However, further randomized controlled studies are re-
quired to compare spine SRS to conventional RT for the treat-
ment of spinal metastasis.
CONCLUSION
In the management of spinal metastasis, stereotactic radio-
surgery appears to provide high rates of tumor control, may be 
less affected by histology, and can be used in previously irradi-
ated patients. However, the quality of available literature on 
spine SRS for metastasis is low or very low. Further high quality 
studies on SRS for spine metastasis are warranted.
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Radiation induced spinal cord injury is exceedingly rare, and 
only a small number of cases have been reported. An early se-
ries by Benzil et al.1) contained no radiation-induced spinal cord 
toxicity, and Gerszten et al.11) found no spinal cord toxicity after 
a follow-up of over 60 months. Ryu et al.30) specifically addressed 
the partial volume tolerance of the spinal cord and complica-
tions of single-dose SRS. They reported a single case of radia-
tion-induced cord injury 13 months after SRS and concluded 
that, whereas the maximum spinal cord tolerance to single-
dose radiation is unknown, partial volume tolerance of the hu-
man spinal cord is at least 10 Gy to 10% of the spinal cord vol-
ume, defined as 6 mm above and below the SRS target. In a 
recent multicenter study of 1075 cases17), only 6 patients devel-
oped delayed radiation-induced myelopathy at a mean of 6.4 
months (range, 2-9 months) after spinal SRS. Recently, Haley et 
al.18) reported that RT had higher acute toxicity rates than SRS 
but encountered no late complications after either treatment 
modality. 
DISCUSSION
From a historical viewpoint, modern LINAC is equipped for a 
wide variety of treatment modalities, including intensity-modu-
lated radiation therapy, stereotactic treatment, and image-guided 
radiation therapy. These advances allow more precise target defi-
nition and conformality, which makes hypofractionation more 
feasible, and provide a potential means of reducing the toxicities 
often observed after administering large fraction sizes18).
The development of Gamma Knife SRS and LINAC-based 
radiosurgery allow the delivery of highly conformal doses of ra-
diation in a single fraction. The first Cyberknife (Accuray) pro-
totypes were used in the 1990s, and in 2001 the FDA granted 
clearance for treatment of extracranial lesions15).
The metastatic disease population is an inherently difficult 
group of patients to study, and patients typically have multiple 
disease sites, poor health, and quality of life. With limited fol-
low-up and survival and other probable confounders such as 
high dose steroid use, retrospective datasets generally report 
better outcomes than reported by randomized trials. 
This systemic literature review reveals the relative safety and 
efficacy of spinal SRS. Despite the significant clinical experience 
and widespread utilization of conventional RT for spinal metas-
tases, stereotactic radiosurgery offers several theoretical advan-
tages as a treatment modality for spinal tumors. Early treatment 
of these lesions before a patient becomes symptomatic and the 
stability of the spine is threatened is obvious advantageous5). 
Furthermore, conformal SRS avoids the need to irradiate large 
segments of the spinal cord. In addition, the early SRS treat-
ment of spinal lesions may obviate the need for extensive spinal 
surgery for decompression and fixation in these already debili-
tated patients and may also avoid the need to irradiate large 6
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